# Evaluation of an Adapted Formula on Atopic Dermatitis.

> **NCT05318300** · NA · UNKNOWN · sponsor: **United Pharmaceuticals** · enrollment: 126 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DIETARY_SUPPLEMENT:** tested formula with fiber
- **DIETARY_SUPPLEMENT:** Control

## Key facts

- **NCT ID:** NCT05318300
- **Lead sponsor:** United Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-24
- **Primary completion:** 2024-04
- **Final completion:** 2024-04
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2023-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05318300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05318300, "Evaluation of an Adapted Formula on Atopic Dermatitis.". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT05318300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*